Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Short Interest Update

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) was the recipient of a significant increase in short interest during the month of October. As of October 31st, there was short interest totalling 5,990,000 shares, an increase of 7.5% from the October 15th total of 5,570,000 shares. Based on an average trading volume of 1,480,000 shares, the days-to-cover ratio is presently 4.0 days.

Hedge Funds Weigh In On Acadia Healthcare

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Point72 Asset Management L.P. lifted its position in shares of Acadia Healthcare by 266.0% during the second quarter. Point72 Asset Management L.P. now owns 2,270,340 shares of the company’s stock worth $153,339,000 after purchasing an additional 1,650,040 shares in the last quarter. Wellington Management Group LLP lifted its holdings in Acadia Healthcare by 12.2% in the 3rd quarter. Wellington Management Group LLP now owns 11,658,253 shares of the company’s stock worth $739,250,000 after buying an additional 1,266,384 shares in the last quarter. Millennium Management LLC boosted its position in Acadia Healthcare by 3,067.8% in the 2nd quarter. Millennium Management LLC now owns 1,090,313 shares of the company’s stock valued at $73,640,000 after buying an additional 1,055,894 shares during the last quarter. Holocene Advisors LP increased its position in shares of Acadia Healthcare by 201.5% during the third quarter. Holocene Advisors LP now owns 972,513 shares of the company’s stock worth $61,667,000 after acquiring an additional 649,997 shares during the last quarter. Finally, William Blair Investment Management LLC lifted its stake in shares of Acadia Healthcare by 20.7% in the second quarter. William Blair Investment Management LLC now owns 3,515,464 shares of the company’s stock worth $237,434,000 after acquiring an additional 604,070 shares in the last quarter.

Analysts Set New Price Targets

ACHC has been the topic of a number of recent analyst reports. Royal Bank of Canada reissued an “outperform” rating and set a $94.00 price target on shares of Acadia Healthcare in a research note on Friday, September 20th. StockNews.com raised Acadia Healthcare from a “sell” rating to a “hold” rating in a research note on Thursday. KeyCorp assumed coverage on shares of Acadia Healthcare in a research note on Friday, October 11th. They set a “sector weight” rating for the company. Barclays decreased their target price on shares of Acadia Healthcare from $83.00 to $76.00 and set an “overweight” rating on the stock in a research report on Monday, September 30th. Finally, Deutsche Bank Aktiengesellschaft upped their price target on shares of Acadia Healthcare from $70.00 to $75.00 and gave the stock a “hold” rating in a research report on Friday, August 2nd. Five analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $86.67.

Acadia Healthcare Price Performance

ACHC opened at $37.82 on Friday. The company has a 50 day moving average of $58.05 and a two-hundred day moving average of $65.60. Acadia Healthcare has a 52-week low of $37.78 and a 52-week high of $87.77. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60. The company has a market cap of $3.51 billion, a P/E ratio of 12.40, a P/E/G ratio of 1.76 and a beta of 1.33.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings results on Wednesday, October 30th. The company reported $0.91 earnings per share for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. The firm had revenue of $815.60 million during the quarter, compared to analysts’ expectations of $819.42 million. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The firm’s revenue was up 8.7% on a year-over-year basis. During the same period in the prior year, the company earned $0.91 EPS. On average, analysts expect that Acadia Healthcare will post 3.38 earnings per share for the current year.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.